Spots Global Cancer Trial Database for mirabegron
Every month we try and update this database with for mirabegron cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists | NCT03049462 | Polycystic Ovar... | Mirabegron B Complex Plus ... | 18 Years - 40 Years | National Institutes of Health Clinical Center (CC) | |
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation | NCT02311569 | Myeloproliferat... Primary Myelofi... Essential Throm... Polycythemia Ve... | Mirabegron | 18 Years - | Swiss Group for Clinical Cancer Research | |
Mirabegron for Treatment of Erectile Dysfunction in Patients With LUTS Secondry to BPH: A Randomized Study | NCT03600766 | BPH Erectile Dysfun... Prostate Hyperp... Erectile Abnorm... Prostatic Neopl... | Mirabegron placebo | 50 Years - 70 Years | Mansoura University | |
Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation | NCT02311569 | Myeloproliferat... Primary Myelofi... Essential Throm... Polycythemia Ve... | Mirabegron | 18 Years - | Swiss Group for Clinical Cancer Research |